Z03.89 Insurance Policy Changes

ICD-10 Z03.89 is officially defined as "Encounter for observation for other suspected diseases and conditions ruled out." code Z03.89 is referenced in 4 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code Z03.89 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 5, 2026Medium impact
Transvaginal Ultrasonography (CPB 0530, reviewed 2026-08-20)
Aetna's Clinical Policy Bulletin 0530 covers transvaginal ultrasonography (CPT 76817 and 76830) when selection criteria are met. Covered indications include assessment of fetal viability and gestational age in the first trimester, assessment of pelvic masses, abnormal uterine bleeding, monitoring of follicular development during infertility therapy, ectopic pregnancy, vasa previa, suspected endometriosis, and post-menopausal bleeding. The policy considers TVUS experimental, investigational or unproven for screening for endometrial, ovarian or other gynecologic cancers and for preoperative prediction of lymph node metastasis in cervical cancer.
Aetna · Identified Aug 17, 2026Medium impact
Herpes Simplex Virus - Screening and Diagnosis (CPB 0433, reviewed 2026-07-01)
Aetna considers serologic assay screening for antibodies to HSV-1 or HSV-2 in asymptomatic members, including those who are pregnant, experimental, investigational, or unproven because its effectiveness has not been established. The HSV CPT codes 86694, 86695, 86696, 87273, 87274, 87483, 87528 and 87529 are covered only when selection criteria are met, and 87483 and 87529 are not covered for asymptomatic members. CPT 87530 (HSV quantification) is not covered for the indications listed, and for HSV diagnosis in persons with active lesions or symptoms, qualitative PCR testing in CPB 0650 applies.
Aetna · Identified Aug 14, 2026Medium impact
Sensory and Auditory Integration Therapy (CPB 0256, reviewed 2026-04-15)
Aetna considers sensory integration therapy and auditory integration therapy (also known as auditory integration training) experimental, investigational, or unproven for the management of persons with various communication, behavioral, emotional, and learning disorders and for all other indications. The effectiveness of these therapies is unproven. CPT code 97533 is not covered for the indications listed in this policy, and the listed ICD-10 codes are not covered for those indications either.
Aetna · Identified Aug 14, 2026Medium impact
Transrectal Ultrasound (CPB 0001, reviewed 2026-03-05)
Aetna considers transrectal ultrasound (TRUS) medically necessary for specific conditions involving the prostate, rectum and surrounding tissues. These include clinical staging of prostate cancer and rectal carcinoma, determining prostate volume before brachytherapy, evaluation of anal or rectal fistula and peri-rectal abscesses, evaluation of hematospermia, assessment of anal sphincter dysfunction, evaluation of benign or malignant peri-rectal tumors, and infertility or azoospermia where an ejaculatory duct cyst is suspected. Metastatic lesions of unknown source with a PSA greater than 10 ng/ml that could originate in the prostate are also covered. TRUS as a screening test for prostate disease, TRUS elastography for evaluation of prostate cancer, and TRUS for cervical cancer are listed as experimental, investigational or unproven. Last review date is 03/05/2026 and next review is 01/14/2027.

Watch Z03.89

Get one email when a payer policy names Z03.89, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code Z03.89?

There are 4 tracked policy changes affecting code Z03.89, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code Z03.89?

Payers that have issued tracked updates for code Z03.89 include: Aetna.

How do I get notified when code Z03.89 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code Z03.89. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code Z03.89?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Transvaginal Ultrasonography (CPB 0530, reviewed 2026-08-20)

Herpes Simplex Virus - Screening and Diagnosis (CPB 0433, reviewed 2026-07-01)

Sensory and Auditory Integration Therapy (CPB 0256, reviewed 2026-04-15)

Transrectal Ultrasound (CPB 0001, reviewed 2026-03-05)

What insurance policy changes affect code Z03.89?

Which payers have updated policy for code Z03.89?

How do I get notified when code Z03.89 policy changes?

Why do payers change policies for code Z03.89?